These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 15498636)

  • 1. Venous Invasion Is a Risk Factor for Recurrence of pT1 Gastric Cancer with Lymph Node Metastasis.
    Takeuchi A; Ojima T; Katsuda M; Hayata K; Goda T; Kitadani J; Tominaga S; Fukuda N; Nakai T; Yamaue H
    J Gastrointest Surg; 2022 Apr; 26(4):757-763. PubMed ID: 35013879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of macroscopic serosal change in subserosal invasion (stage T3) gastric cancer.
    Zhao B; Mei D; Zhang J; Zou S; Lu H; Xu H; Huang B
    Ann R Coll Surg Engl; 2019 Apr; 101(4):249-255. PubMed ID: 30602290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients.
    Song DH; Kim N; Jo HH; Kim S; Choi Y; Oh HJ; Lee HS; Yoon H; Shin CM; Park YS; Lee DH; Kang SH; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH; Ahn S; Surh YJ
    Gut Liver; 2024 Mar; 18(2):231-244. PubMed ID: 36987384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour deposits are a significant prognostic factor in gastric cancer - a systematic review and meta-analysis.
    Graham Martínez C; Knijn N; Verheij M; Nagtegaal ID; van der Post RS
    Histopathology; 2019 May; 74(6):809-816. PubMed ID: 30376189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-Dependent Effects of Prognostic Factors in Advanced Gastric Cancer Patients.
    Kwon JO; Jin SH; Min JS; Kim MS; Lee HW; Park S; Yu HJ; Bang HY; Lee JI
    J Gastric Cancer; 2015 Dec; 15(4):238-45. PubMed ID: 26819803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sixth and seventh tumor-node-metastasis staging system compared in gastric cancer patients.
    Zurleni T; Gjoni E; Ballabio A; Casieri R; Ceriani P; Marzoli L; Zurleni F
    World J Gastrointest Surg; 2013 Nov; 5(11):287-93. PubMed ID: 24520426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.
    Bilici A; Dane F; Seker M; Ustaalioglu BB; Aliustaoglu M; Temiz S; Gezen C; Yavuzer D; Aksu G; Mayadagli A; Gumus M; Uygun K; Turhal NS
    Dig Dis Sci; 2011 Nov; 56(11):3226-34. PubMed ID: 21660487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients.
    Scartozzi M; Galizia E; Verdecchia L; Berardi R; Graziano F; Catalano V; Giordani P; Mari D; Silva RR; Marmorale C; Zingaretti C; Cascinu S
    Br J Cancer; 2006 Aug; 95(4):445-9. PubMed ID: 16880789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.
    Kobayashi M; Tsuburaya A; Nagata N; Miyashita Y; Oba K; Sakamoto J
    Gastric Cancer; 2006; 9(2):114-9. PubMed ID: 16767367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
    Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
    Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.
    Fotia G; Marrelli D; De Stefano A; Pinto E; Roviello F
    Eur J Surg Oncol; 2004 Nov; 30(9):930-4. PubMed ID: 15498636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
    Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
    Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.